FORMA THERAPEUTICS HOLDINGS (FMTX) Forecast, Price Target & Analyst Ratings

NASDAQ:FMTX • US34633R1041

Current stock price

20.01 USD
+0.03 (+0.15%)
At close:
20.01 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FORMA THERAPEUTICS HOLDINGS (FMTX).

Forecast Snapshot

Consensus Price Target

Price Target
$21.01
+ 5.01% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 11, 2022
Period
Q3 / 2022
EPS Estimate
-$1.10
Revenue Estimate
1.285M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
75.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$21.01
Upside
+ 5.01%
From current price of $20.01 to mean target of $21.01, Based on 12 analyst forecasts
Low
$20.20
Median
$20.40
High
$24.15

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for FMTX. The average price target is 21.01 USD. This implies a price increase of 5.01% is expected in the next year compared to the current price of 20.01.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FMTX Current Analyst RatingFMTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

FMTX Historical Analyst RatingsFMTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
75.00%
FMTX was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about FMTX.
In the previous month the buy percentage consensus was at a similar level.
FMTX was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-09-02OppenheimerDowngrade Outperform -> Perform
2022-09-02Credit SuisseDowngrade Outperform -> Neutral
2022-09-02JefferiesDowngrade Buy -> Hold
2022-09-02HC Wainwright & Co.Downgrade Buy -> Neutral
2022-05-27SVB LeerinkMaintains Outperform
2021-11-12SVB LeerinkMaintains Outperform
2021-08-17HC Wainwright & Co.Maintains Buy
2021-08-02Craig-HallumInitiate Buy
2021-06-11SVB LeerinkMaintains Outperform
2021-03-31HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 11, 2022
Period
Q3 / 2022
EPS Estimate
-$1.10
Revenue Estimate
1.285M
Revenue Q2Q
N/A
EPS Q2Q
-20.83%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

FMTX is expected to report earnings on 11/11/2022. The consensus EPS estimate for the next earnings is -1.1 USD and the consensus revenue estimate is 1.29M USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
FMTX revenue by date.FMTX revenue by date.
164.1M100.6M
-38.70%		170.003K
-100.00%		1.02M15.494M
1,419.04%		3.498M
-77.42%		8.574M
145.10%		21.435M
150.00%
EBITDA
YoY % growth
FMTX ebitda by date.FMTX ebitda by date.
13.23M-32.53M
-345.88%		-130.278M
-277.56%		-178.112M
-40.38%		-217.788M
-26.31%		-220.971M
-1.46%		-266.454M
-20.58%		-232.436M
12.77%		-206.816M
11.02%
EBIT
YoY % growth
FMTX ebit by date.FMTX ebit by date.
9.7M-35.2M
-462.89%		-129.366M
-252.56%		-173.15M
-40.20%		-209.602M
-20.47%		-222.411M
-6.11%		-278.664M
-25.29%		-230.303M
17.35%		-194.142M
15.70%
Operating Margin
FMTX operating margin by date.FMTX operating margin by date.
5.91%-34.99%-76,095.88%N/A-20,549.23%-1,435.45%-7,965.94%-2,686.06%-905.72%
EPS
YoY % growth
FMTX eps by date.FMTX eps by date.
N/AN/A-3.72-3.63
1.80%		-4.35
-19.14%		-3.68
15.44%		-3.87
-5.13%		-3.99
-3.09%		-4.19
-5.15%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-1.10
-20.83%		-1.13
-6.81%		-0.90
2.94%		-1.07
2.64%		-1.12
-2.04%		-1.14
-0.45%
Revenue
Q2Q % growth		1.285M469.2K11.73M4.227M183.6K
-85.71%		257.04K
-45.22%
EBITDA
Q2Q % growth		-54.207M
-26.77%		-61.816M
-26.89%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-52.995M
-22.02%		-54.863M
-9.10%		-43.372M
2.34%		-51.65M
2.54%		-56.669M
-6.93%		-57.069M
-4.02%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FMTX Yearly Revenue VS EstimatesFMTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2022 2023 2024 2025 2026 50M 100M 150M
FMTX Yearly EPS VS EstimatesFMTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
0.88%
EPS Next 5 Year
-2.50%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FORMA THERAPEUTICS HOLDINGS / FMTX Forecast FAQ

What do analysts expect the price target to be for FORMA THERAPEUTICS HOLDINGS (FMTX)?

12 analysts have analysed FMTX and the average price target is 21.01 USD. This implies a price increase of 5.01% is expected in the next year compared to the current price of 20.01.

When does FORMA THERAPEUTICS HOLDINGS (FMTX) report earnings?

FORMA THERAPEUTICS HOLDINGS (FMTX) will report earnings on 2022-11-11, before the market open.

What are the consensus estimates for FMTX stock next earnings?

The consensus EPS estimate for the next earnings of FORMA THERAPEUTICS HOLDINGS (FMTX) is -1.1 USD and the consensus revenue estimate is 1.29M USD.

How many analysts have analysed FORMA THERAPEUTICS HOLDINGS (FMTX)?

The number of analysts covering FORMA THERAPEUTICS HOLDINGS (FMTX) is 12.